Jeremy Aaron Bezaire is an inventor based in North Reading, Massachusetts. His patent work addresses bioprocessing, including pH-probe calibration verification and continuous feeding of cell cultures. He is associated with Amgen Inc. and holds 2 patents.

Latest Patents

Bezaire’s listed patents include “In-process verification of calibration status of pH probes” and “Pre-programmed non-feedback controlled continuous feeding of cell cultures.”

“In-process verification of calibration status of pH probes” describes a process for low-pH viral inactivation. An elution pool is acidified in a first vessel, checked with pH probes, and transferred to a second vessel for further pH verification and a holding period intended to reduce viral concentration. After neutralization and filtration, the pool moves to a third vessel. Meanwhile, known-pH buffer is used to check the probes in the first and second vessels and determine whether recalibration is needed.

“Pre-programmed non-feedback controlled continuous feeding of cell cultures” presents a continuous feeding method based on substrate mass balance in a bioreactor. The method does not depend on instrument, probe, or operator feedback, and offers an alternative to bolus feeding for culture growth and maintenance.

Career Highlights

Bezaire’s patent portfolio reflects work on process control and operational reliability in biomanufacturing. One invention incorporates probe checks into the production sequence, while the other describes a pre-programmed feeding approach that operates without feedback.

Collaborations

Bezaire is associated with Amgen Inc. His listed coworkers include Marco DeLiso and Andrew Cavigli.

Conclusion

Jeremy Aaron Bezaire’s two patents focus on practical bioprocessing methods, combining in-process pH-probe verification with non-feedback continuous feeding of cell cultures.

Profile summary based on public USPTO records.